SOS Limited Announces Development of Tier III Modular Data Center at Longfellow Ranch, Texas
NEW YORK, Dec. 22, 2025 /PRNewswire/ -- SOS Limited (NYSE: SOS) ("SOS"…
Velo Announces Integration of USD1 With World Liberty Financial to Strengthen PayFi Infrastructure Across Asia
SINGAPORE, Dec. 22, 2025 /PRNewswire/ -- Velo, a PayFi infrastructure protocol focused on…
Bitmine Immersion (BMNR) Announces ETH Holdings Reach 4.066 Million Tokens, and Total Crypto and Total Cash Holdings of $13.2 Billion
Bitmine now owns 3.37% of the ETH token supply, two-thirds of the…
Menarini Silicon Biosystems announces PACE trial biomarker analysis results confirming clinical utility of CELLSEARCH CTC enumeration to guide treatment decisions in a specific metastatic breast cancer subtype
The secondary analysis of the PACE trial highlights the value of counting…
Biosplice Therapeutics Announces First Patient Dosed in InvestigatorInitiated Phase 1 Clinical Trial of Cirtuvivint and Olaparib in BRCA/HRD PlatinumResistant Ovarian Cancer
SAN DIEGO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”),…
Alvotech announces European launch of first-in-market biosimilar to Simponi (golimumab) globally by partner Advanz Pharma
Introduction of AVT05 supported by NHS England tender award in the United…
MMA Announces SMARTIES X Global 2025 Winners: Honoring Marketing That Drives Global Impact
NEW YORK, Dec. 19, 2025 /PRNewswire/ -- The Marketing + Media Alliance…
Aptose Biosciences Announces Rescheduling of Special Meeting of Shareholders to Approve the Acquisition by Hanmi Pending Final Clearance from SEC
SAN DIEGO and TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences…
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 19, 2025 16:15 ET | Source: Zenas BioPharma WALTHAM, Mass., Dec.…
Rezubio Announces $20 Million Series A Financing to Advance the Membrane-Anchored Therapeutics Platform and Company Pipeline, with Lead Program in Obesity and Diabetes
ZHUHAI, China, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Rezubio, a China-based biotechnology…
